These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Bioequivalence of allopurinol and its metabolite oxipurinol in two tablet formulations. Guerra P, Frias J, Ruiz B, Soto A, Carcas A, Govantes C, Montuenga C, Fernández A. J Clin Pharm Ther; 2001 Apr; 26(2):113-9. PubMed ID: 11350534 [Abstract] [Full Text] [Related]
28. Comparative bioavailability of two capsule formulations of mefenamic acid. Rawashdeh NM, Najib NM, Jalal IM. Int J Clin Pharmacol Ther; 1997 Aug; 35(8):329-33. PubMed ID: 9266288 [Abstract] [Full Text] [Related]
30. Bioequivalence study of two capsule formulations of omeprazole. Pillai GK, Salem MS, Najib NM, Jilani J, Hasan MM, Ghanem E, Sallam E, Shubair MS, al-Delq S. Acta Pharm Hung; 1996 Nov; 66(6):231-5. PubMed ID: 9604487 [Abstract] [Full Text] [Related]
31. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop. Luckow V, Della Paschoa O. Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390 [Abstract] [Full Text] [Related]
32. Bioequivalence study of two oral formulations of clarithromycin in human male subjects. Khan MK, Khan MF, Mustafa G, Sualah M. Pak J Pharm Sci; 2011 Jan; 24(1):43-6. PubMed ID: 21190917 [Abstract] [Full Text] [Related]
33. Comparative pharmacokinetics of two brands of atenolol following a single oral administration. Irshaid YM, Rawashdeh NM, Awwadi FF, Kato MK. Int J Clin Pharmacol Ther; 1996 Oct; 34(10):457-61. PubMed ID: 8897086 [Abstract] [Full Text] [Related]
34. Comparative pharmacokinetics and bioequivalence of two 50 mg atenolol tablet formulations in healthy Korean male volunteers. Chang MJ, Shin WG. Arzneimittelforschung; 2012 Sep; 62(9):410-3. PubMed ID: 22791245 [Abstract] [Full Text] [Related]
35. Comparative bioavailability of two brands of ciprofloxacin. Seth SD, Beotra A, Seth S. J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961 [Abstract] [Full Text] [Related]
36. Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension. Shah A, Liu MC, Vaughan D, Heller AH. J Antimicrob Chemother; 1999 Mar; 43 Suppl A():49-54. PubMed ID: 10225572 [Abstract] [Full Text] [Related]
37. Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers. Harahap Y, Prasaja B, Indriati E, Lusthom W, Lipin. Int J Clin Pharmacol Ther; 2007 Jun; 45(6):373-6. PubMed ID: 17595895 [Abstract] [Full Text] [Related]
38. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs. Papich MG. Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062 [Abstract] [Full Text] [Related]
39. Truncated AUC in the evaluation of fluconazole bioequivalence. A cross-over, randomised, open-label study in healthy volunteers. Portolés A, Almeida S, Terleira A, de Pablo I, Filipe A, Cruz Caturla M, Moreno A. Arzneimittelforschung; 2004 Jul; 54(11):752-6. PubMed ID: 15612616 [Abstract] [Full Text] [Related]
40. Comparative bioavailability of two formulations of levofloxacin and effect of sex on bioequivalence analysis. Data from a randomised, 2 x 2 crossover trial in healthy volunteers. Almeida S, Filipe A, Almeida A, Wong H, Caparrós N, Tanguay M. Arzneimittelforschung; 2005 Jul; 55(7):414-9. PubMed ID: 16080281 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]